Novel FXR agonist nelumal A suppresses colitis and inflammation-related colorectal carcinogenesis.
Miyazaki T, Shirakami Y, Mizutani T, Maruta A, Ideta T, Kubota M, Sakai H, Ibuka T, Genovese S, Fiorito S, Taddeo VA, Epifano F, Tanaka T, Shimizu M.
Miyazaki T, et al. Among authors: ibuka t.
Sci Rep. 2021 Jan 12;11(1):492. doi: 10.1038/s41598-020-79916-5.
Sci Rep. 2021.
PMID: 33436792
Free PMC article.